- Home
- FCT vs SERA Comparison
FCT vs SERA Comparison
Compare FCT & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCT
- SERA
- Stock Information
- Founded
- FCT 2004
- SERA 2008
- Country
- FCT United States
- SERA United States
- Employees
- FCT N/A
- SERA N/A
- Industry
- FCT Finance Companies
- SERA Precision Instruments
- Sector
- FCT Finance
- SERA Health Care
- Exchange
- FCT Nasdaq
- SERA Nasdaq
- Market Cap
- FCT 268.9M
- SERA 258.3M
- IPO Year
- FCT N/A
- SERA 2021
- Fundamental
- Price
- FCT $10.34
- SERA $6.49
- Analyst Decision
- FCT
- SERA
- Analyst Count
- FCT 0
- SERA 0
- Target Price
- FCT N/A
- SERA N/A
- AVG Volume (30 Days)
- FCT 106.8K
- SERA 57.4K
- Earning Date
- FCT 01-01-0001
- SERA 11-06-2024
- Dividend Yield
- FCT 11.29%
- SERA N/A
- EPS Growth
- FCT N/A
- SERA N/A
- EPS
- FCT N/A
- SERA N/A
- Revenue
- FCT N/A
- SERA $94,000.00
- Revenue This Year
- FCT N/A
- SERA N/A
- Revenue Next Year
- FCT N/A
- SERA $2,018.04
- P/E Ratio
- FCT N/A
- SERA N/A
- Revenue Growth
- FCT N/A
- SERA N/A
- 52 Week Low
- FCT $9.45
- SERA $1.65
- 52 Week High
- FCT $10.42
- SERA $12.36
- Technical
- Relative Strength Index (RSI)
- FCT 49.33
- SERA 47.81
- Support Level
- FCT $10.16
- SERA $7.56
- Resistance Level
- FCT $10.34
- SERA $8.78
- Average True Range (ATR)
- FCT 0.09
- SERA 0.58
- MACD
- FCT -0.00
- SERA 0.03
- Stochastic Oscillator
- FCT 55.52
- SERA 34.36
About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest
First Trust Senior Floating Rate Income Fund II is the United States based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, the fund attempts to preserve capital. The fund seeks to achieve the objectives by investing in a portfolio of senior floating-rate loan interests. Its portfolio of investments consists of aerospace and defense, agricultural products, broadcasting, cable and satellite, electric utilities and other sectors.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.